Abstract:

In the current study, two marketed formulations VELGUT® (combination of prebiotic and probiotics) and VIZYLAC® (probiotic only) were assessed for a protective effect against carbon tetrachloride (CCl4) induced chronic liver injury model in rats. Rats were randomly divided into four groups. The normal control group was treated with normal saline (C1) and CCl4 treated group was treated with 1 ml/kg intraperitoneal injection of CCl4 one time a day for 10 days followed by two times in a week for 49 days (C2). Test groups composed of the oral treatment of VELGUT (1 mg kg-1) along with CCl4 (T1) and oral treatment of VIZYLAC (4 mg kg-1) along with CCl4 (T2). At the end of the treatment, various serum biochemical parameters like alanine aminotransferase (ALT), aspartate aminotransferase, (AST), alkaline phosphatase (ALP), direct bilirubin, total protein, and albumin levels were measured. Serum AST, ALT, ALP, and direct bilirubin of the groups T1 and T2 were found to be significantly lower as compared to group C1. The level of total protein and albumin was improved in the groups T1 and T2. The level of MDA, glucose and cholesterol was significantly decreased (p<0.05) in the groups T1 and T2 as compared to group C2.

Keywords: